Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmathen Global BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10794
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain killers, besides topical antifungals, corticosteroids, and vitamins and minerals. Pharmathen provides comprehensive backward integrated services to customers, which include API systhesis to formulation, and production and supply of finished products. It also offers services which include drug safety and pharmacovigilance, third party auditing, regulatory affairs, quality management, medical writing and consulting services, intellectual property, and scientific operations. The company markets its products in Europe, North America, South Africa, Latin America, Middle East and North Africa, Asia and Australia. Pharmathen is headquartered in Amstelveen, Netherlands.

Pharmathen Global BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
BC Partners to Acquire Majority Stake in Pharmathen 10
Partnerships 11
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Asset Transactions 17
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV – Key Competitors 18
Pharmathen Global BV – Key Employees 19
Pharmathen Global BV – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Pharmathen Global BV, Pharmaceuticals & Healthcare, Key Facts 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BC Partners to Acquire Majority Stake in Pharmathen 10
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV, Key Competitors 18
Pharmathen Global BV, Key Employees 19
Pharmathen Global BV, Other Locations 20
Pharmathen Global BV, Subsidiaries 20

List of Figures
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Wyndham Destinations, Inc.:企業の戦略・SWOT・財務情報
    Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Epcor Utilities Inc-エネルギー分野:企業M&A・提携分析
    Summary Epcor Utilities Inc. (Epcor), a subsidiary of City of Edmonton, is an energy utility which offers electricity and water services. It builds, owns and operates electrical transmission and distribution networks; and water and wastewater treatment facilities and infrastructure. The company prov …
  • Senvion SA-エネルギー分野:企業M&A・提携分析
    Summary Senvion S.A. (Senvion), formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey , foundation construction, transport and installation, and service …
  • Perdue Farms Inc.:企業の戦略・SWOT・財務分析
    Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report Summary Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Clayton Homes Inc:企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • BASF SE:企業の戦略・SWOT・財務情報
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Pattern Energy Group Inc.:企業のM&A・事業提携・投資動向
    Pattern Energy Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pattern Energy Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • BT Global Services Limited:企業の戦略的SWOT分析
    BT Global Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Jura Energy Corp (JEC):企業の財務・戦略的SWOT分析
    Jura Energy Corp (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kyowa Hakko Kirin Co., Ltd.:企業の戦略・SWOT・財務情報
    Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Krosaki Harima Corporation:企業の戦略・SWOT・財務情報
    Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report Summary Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alfa Laval AB (ALFA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • PharmAthene Inc (PIP)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bios …
  • Lee Enterprises, Inc. (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises, Inc. (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆